Brief: Epigenomics: Epi Procolon included in newly issued USPSTF guidelines for colorectal cancer screening
16/06/2016 09:15
June 16 (Reuters) - Epigenomics AG ECXn.DE :
* Epi Procolon included in newly issued USPSTF guidelines
for colorectal cancer screening
* USPSTF guidelines expected to support adoption of Epi
Procolon by patients, physicians and insurers
Source text for Eikon: ID:nEQ7LPjxCa
Further company coverage: ECXn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns